Trials / Unknown
UnknownNCT03715699
Leflunomide Treatment for IgG4-RD
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study is an open-label randomized controlled trial aiming to investigate whether the efficacy and side effect of Leflunpomide plus glucocorticoid.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Prednisone | Prednisone: started with prednisone alone 0. 6-0. 8mg/kg.d for 1 month, decreased 5mg per 2 weeks, and maintained at 7.5mg to 10mg/d to 12 months. |
| DRUG | Prednisone and Leflunomide | Prednisone: started with prednisone 0. 6-0. 8mg/kg.d for 1 month, decreased 5mg per 2 weeks, maintained at 7.5mg to 10mg/d to 12 months. Leflunomide: 20mg qd for 6 months and 10mg qd for 6 months. |
Timeline
- Start date
- 2018-07-01
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
- First posted
- 2018-10-23
- Last updated
- 2018-10-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03715699. Inclusion in this directory is not an endorsement.